Who invests in TNBC

242 private investors in 50 companies with TNBC programs, including past ones: 87 rounds.

Funding timeline

Round stage:Founding & seedSeries ASeries BSeries C & later privateRound not disclosed
Size not disclosedYear estimatedBubble area = round size (USD)Click a bubble or a company for details

Disclosed per year (USD)

Active (25)

Discontinued (25)

200920102011201220132014201520162017201820192020202120222023202420252026≈$1.5B$92.5M

Graph View

Investor type:
Independent VC & venture creation (140)Pharma & corporate VC (29)Crossover & family office (51)Accelerators (0)University, non-profit & public (22)
Investors are grouped by the stage of their earliest round; node height = number of links (n) Click a name, ribbon or stage heading for details · Shift/⌘/Ctrl-click to compare
FOUNDING & SEED (9)SERIES A (81)SERIES B (98)SERIES C & LATER PRIVATE (51)ROUND NOT DISCLOSED (3)Apple Tree Partners (ATP) (1)Catalio Capital Management (1)CommonWealth Angels (1)Jiangsu Hengrui Pharmaceuticals (1)Northern Light Venture Capital (1)Polaris Partners (2)Quark Venture (1)Virginia Innovation Partnership Cor… (1)Virginia Tech Carilion Seed Fund (1)6 Dimensions Capital (2)Aberdare Ventures (1)Abingworth (3)ABio-X (1)Adams Street Partners (1)Amgen Ventures (3)aMoon (1)ARCH Venture Partners (4)Arix Bioscience (1)Astellas Venture Management (2)Beijing Changping Development (北京昌发… (1)Beijing Shoufa Development (首发展) (1)BeOne Medicines (1)Bohe Fund (薄荷基金) (1)Bristol Myers Squibb (4)Cambridge Innovation Capital (1)Camford Capital (2)Canica (1)Chang'an Capital (1)Chiesi Ventures (1)Cornell University (1)Delta Capital (1)Domain Associates (1)Evotec (1)FACIT (1)Frazier Life Sciences (2)Gaorong Capital (1)Genesys Capital (1)Golden Ventures (1)GV (1)Hanyi Capital (翰颐资本) (1)Harel Insurance (1)Hatteras Venture Partners (1)HealthCap (1)Healthlink Capital (1)Heron Rock Fund (1)Hillhouse Investment (高瓴) (1)HongShan (1)Huagai Capital (3)IDG Capital (1)InterWest Partners (1)Israel Biotech Fund (1)Johnson & Johnson Innovation – JJDC (1)K2VC (1)Kaitai Capital (2)Kensington Capital Partners (1)King Star Capital (1)Lifespan Investments (1)Lightstone Ventures (3)LYFE Capital (1)MedImmune Ventures (1)MPM BioImpact (MPM Capital) (2)New Enterprise Associates (NEA) (1)NYC Life Sciences Fund (1)Ocean Road Advisors (1)Oceanpine Capital (1)OrbiMed (5)Oriental Fortune Capital (1)Oriza Holdings (元禾控股) (3)Pappas Capital (1)Pfizer (2)ProQuest Investments (1)Redmile Group (1)Rosetta Capital (1)Sandwater (1)SDIC CMC Investment (国投招商) (1)Seroba Life Sciences (1)Sofinnova Investments (2)Suzhou Likang (苏州礼康) (1)TaiAn Technologies (1)Takeda Ventures (1)Tianjin Huizhi (天津汇智) (1)TPG (1)Trinity Innovation Fund (1)Varian Medical Systems (1)venBio Partners (1)Versant Ventures (3)Vertex Ventures HC (1)WuXi Biologics (1)Zero2IPO Capital (清科产投) (1)Zhangjiang Haoheng (张江浩珩) (2)3B Future Health Fund (1)3E Bioventures Capital (1)3W Fund Management (1)8VC (1)AbbVie Ventures (1)Advanced Technology Ventures (1)Alaska Permanent Fund Corporation (1)Alexandria Venture Investments (1)Alpha Win Capital (1)ALSA Ventures (1)Altitude Life Science Ventures (1)Alumni Ventures (1)ArrowMark Partners (1)Bioluminescence Ventures (1)BioMed Ventures (1)British Patient Capital (1)BVF Partners (1)Canaan Partners (1)Cancer Research Institute, New York… (1)Caribou Property (1)Casdin Capital (2)Cormorant Asset Management (3)Decheng Capital (2)Delphi Ventures (1)Eight Roads Ventures (2)Epidarex Capital (1)Eshelman Ventures (2)Euclidean Capital (2)F-Prime Capital (4)Farallon Capital Management (1)Fidelity Investments (1)Flagship Pioneering (1)Foresite Capital (2)Fortune Ocean Growth Fund (1)Fund+ (1)GBA Fund (1)GP Healthcare Capital (金浦健康) (1)Green Pine Capital Partners (松禾资本) (1)Hartford HealthCare Endowment (2)Hercules Capital (1)HM Capital (1)Huizenga Capital Management (1)Intuitive Ventures (1)Invus (2)Janus Henderson Investors (4)KdT Ventures (1)Khosla Ventures (1)Kingdon Capital Management (1)Kinnevik (1)LifeSci Venture Partners (1)Lilly Asia Ventures (5)Logos Capital (4)Lumira Ventures (1)Magnetic Ventures (1)Marshall Wace (1)Matrix Capital Management (1)Mayo Clinic (1)Mirae Asset Capital (1)Mission Bay Capital (1)Mission BioCapital (1)Monashee Investment Management (1)Morgenthaler Ventures (1)Mount Sinai Innovation Partners (1)NexPoint (1)Nextech Invest (4)Novartis (1)Novartis Venture Fund (2)Novo Holdings (3)NRL Capital (纽尔利资本) (1)Osage University Partners (2)Piedmont Capital (1)Piper Heartland Healthcare Capital (1)Pitango (1)Pivotal bioVenture Partners (1)Prosperous Alliance (1)PSP Investments (1)Quan Capital (1)RA Capital Management (7)Regeneron Pharmaceuticals (1)Regeneron Ventures (1)Rock Springs Capital (1)Samsara BioCapital (2)Schroders Capital (1)Sino Biopharmaceutical (2)SoftBank Vision Fund (1)SR One (2)Stine Seed Farms (1)Surveyor Capital (Citadel) (2)Tekla Capital Management (1)The Column Group (3)Third Rock Ventures (1)TIO Bioventures (1)Trinitas Capital (1)U.S. Venture Partners (2)UC Investments (University of Calif… (1)Venrock (2)Vida Ventures (2)YUNION Healthcare Fund (楹联健康基金) (2)Adage Capital Management (2)Affinity Asset Advisors (1)Ally Bridge Group (3)Altrium Capital Management (1)AstraZeneca (2)AT Impf (Strüngmann family office) (2)Baker Bros. Advisors (1)Bayer (1)Bilinxing Ventures (比邻星创投) (1)Boxer Capital (2)CBC Group (1)Chengxiang Capital (澄翔资本) (1)CS Capital (SDIC Unity / 国投招商) (1)dievini Hopp BioTech holding (1)EcoR1 Capital (1)EDBI (1)Eli Lilly (3)Enran Ventures (恩然创投) (1)Fosun Health Capital (复健资本) (1)HBM Healthcare Investments (2)Heritas Capital (1)Infinity Capital (英飞尼迪) (1)Kunlun Capital (昆仑资本) (1)Longitude Capital (1)Longwood Fund (1)Matrix Partners China (1)Medicxi (2)MIG Capital (1)Mirae Asset Venture Investment (1)Morningside Ventures (1)Octagon Capital Advisors (3)Omega Funds (1)Pandect Bioventures (1)Pavilion Capital (2)Perceptive Advisors (1)Pfizer Ventures (1)PFM Health Sciences (1)Pudong Venture Capital (浦东创投) (1)Pureos Bioventures (1)Qiming Venture Partners (1)RTW Investments (1)Shanghai Biomedical Industry Fund (… (1)Shenzhen Capital Group (深创投) (1)SK Inc. (1)Soleus Capital (1)T. Rowe Price (3)Viking Global Investors (2)Wellington Management (4)Wellington Partners (1)Worldstar (万汇资本) (1)Yanchuang Capital (燕创资本) (1)Droia Ventures (4)Meusinvest (Noshaq) (1)Spinventure (1)ACTIVE (25)DISCONTINUED (25)A2 Biotherapeutics (8)ACOMHAL RESEARCH, INC (3)Adcentrx Therapeutics (5)Asher Biotherapeutics (12)BioNTech (1)Circle Pharma (8)Convert Pharmaceuticals (3)Effector Therapeutics (11)Epsilogen (7)Hummingbird Bioscience (15)Immatics (4)Marengo Therapeutics (1)NiKang Therapeutics (13)OncoC4 (4)ProteinQure (3)Reistone Biopharma (6)Repertoire Immune Medicines (5)SAPIENCE THERAPEUTICS, INC (6)Simcha Therapeutics (6)Singlomics Biopharmaceuticals (6)Strand Therapeutics (7)SURGE Therapeutics (10)Teon Therapeutics (6)Tizona Therapeutics (7)Treadwell Therapeutics (6)AstraZeneca (Fusion Pharmaceutical… (10)Ayala Pharmaceuticals (5)BioAtla (5)Boundless Bio (6)Calithera Biosciences (8)Carrick Therapeutics (7)Clovis Oncology (8)Cyteir Therapeutics (6)Cytovation (2)Duality Biologics (9)G1 Therapeutics (5)Genmab (ProfoundBio) (19)HiberCell (11)InxMed (5)iTeos Therapeutics (5)Laekna Therapeutics (7)Merck & Co. (VelosBio) (19)Moderna (2)Regeneron Pharmaceuticals (Checkmat… (8)Sichuan Kelun-Biotech (4)Sino Biopharmaceutical (LaNova Medi… (5)Tempest Therapeutics (6)Turnstone Biologics (4)Volastra Therapeutics (9)Vyriad (4)

Not on this map

Current owners of active programs (repurposing trials left out) with no private round on this page.

Big pharma and academic (own budget) (41)

AbbVie, Astellas Pharma, AstraZeneca, Bayer, Bristol Myers Squibb, Canadian Cancer Trials Group, Cedars-Sinai Medical Center, City of Hope, Dartmouth-Hitchcock Medical Center, Eisai, Eli Lilly, Fundació Clínic Barcelona, Gilead Sciences, GSK, H. Lee Moffitt Cancer Center and Research Institute, Incyte, Jiangsu Hengrui Pharmaceuticals, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Menarini, Merck & Co., Merck KGaA, Novartis, Otsuka Holdings, Pfizer, Pfizer (Seagen), Regeneron Pharmaceuticals, Roche, Roswell Park, Second Affiliated Hospital of Guangzhou Medical University, Sino Biopharmaceutical, Sino Biopharmaceutical (Chia Tai Tianqing), The Methodist Hospital Research Institute, UNC Lineberger Comprehensive Cancer Center, Universidad Nacional de Colombia, University Health Network, Toronto, University of Illinois Chicago, University of Southern California, University of Washington, Washington University in St. Louis, Xiaorong Sun

Other companies (no public data about private funding) (154)

A&G Pharmaceutical, Adagene, Adlai Nortye, ADT Pharmaceuticals, Adze Biotechnology, Agenus, AGONOX, INC, Akeso, ALX Oncology, AmunBio, Anixa Biosciences, AntiCancer, Arcus Biosciences, ARREVUS, INC, BeBetter Med, Beijing Biostar Pharmaceuticals, Beijing Biotech, BeOne Medicines (FKA BeiGene), Bicycle Therapeutics, Biocad, Biocity Biopharmaceutics, Biocytogen, BioLite, BioPhoenix, Birdie Biopharmaceuticals, BreakBio, Brooklyn ImmunoTherapeutics, CADRE BIOSCIENCE, Cardiff Oncology, Celcuity, Cellectar Biosciences, Cellectis, Changchun GeneScience Pharmaceuticals, Compass Therapeutics, Convalife (Shanghai), Corcept Therapeutics, CoRegen, CREEGH PHARMACEUTICALS, INC, CSPC Pharmaceutical, CULNEXIN THERAPEUTICS, INC, CytoDyn, CYTONUS THERAPEUTICS, INC, Dantari, DAUNTLESS BIOTHERAPEUTICS, INC, Day One Biopharmaceuticals, Debiopharm, DNATWO, INC, DuChem Bio, Eddingpharm (Genor Biopharma), ENZYME BY DESIGN, INC, Essen Biotech, Evestra, Exelixis, Flow Pharma, Genmab, Henan Ruida Bio-Tech Medicine, Hinova Pharmaceuticals, Huabo Biopharm, IDEAYA Biosciences, ImmuneOncia Therapeutics, ImmuneOnco Biopharmaceuticals, Immunomic Therapeutics, IMMUNOVA THERAPEUTICS, Imugene, Inhibrx Biosciences (FKA Inhibrx), Innocrin Pharmaceuticals, Innova Therapeutics, Innovent Biologics, Intensity Therapeutics, INTRA THERAPEUTICS, Iovance Biotherapeutics, ISOPRENE PHARMACEUTICALS, INC, Jacobio Pharmaceuticals, JenKem Technology, Jiangsu Alphamab, Jiangsu Hansoh Pharmaceutical, Jina Pharmaceuticals, JW Pharmaceutical, Kolon Pharmaceuticals, Lantern Pharma, Light Chain Bioscience (Novimmune), LOXIGEN, INC, Lumara Bio Oncologics, Mabwell (Shanghai) Bioscience, Madera Therapeutics, Mainline Biosciences, Marker Therapeutics, MBQ Pharma, Memgen, Minerva Biotechnologies, MODULATION THERAPEUTICS, INC, MOLECULAR THERANOSTICS, Monopar Therapeutics, Nanjing Immunophage Biotech, Nanjing Leads Biolabs, NATSAR PHARMACEUTICALS, INC, NEC Bio, NIROGYONE THERAPEUTICS, Nurix Therapeutics, OBI Pharma, Onchilles Pharma, Oncolytics Biotech, OncoPep, OncoTherapy Science, ONCOTHERAPY SOLUTIONS, Oncovir, OncXerna Therapeutics, Orinove, PEARL SCIENTIFIC, Pharosgen, Phoenix Molecular Designs, Phost'In Therapeutics, ProDa BioTech, PROMILEAD, Pure Biologics, Pyxis Oncology, Qilu Pharmaceutical, QUADRIGA BIOSCIENCES, INC, Qurient, RECOMBINATION THERAPEUTICS, RemeGen, Rhizen Pharmaceuticals, Scancell, SEAK THERAPEUTICS, SENEX BIOTECHNOLOGY, INC, Senhwa Biosciences, Shanghai Escugen Biotechnology, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Henlius Biotech, Shanghai Junshi Biosciences, Shenzhen Majory Biotech, Sichuan Baili Pharmaceutical (SystImmune), SillaJen, STINGRAY THERAPEUTICS, INC, Sumitomo Pharma, Summit Therapeutics, SUNHO (China) BioPharmaceutical, SYMPHONY BIOSCIENCES, INC, Syndax Pharmaceuticals, SynDevRx, Telomir Pharmaceuticals, Thena Biotech, Theratechnologies, Tianjin ConjuStar Biologics, TOOMER THERAPEUTICS, INC, TransCode Therapeutics, TRIO PHARMACEUTICALS INC, VONA ONCOLOGY, WEATHERWAX BIOTECHNOLOGIES CORPORATION, WINDOW THERAPEUTICS, INC, Xenothera, Xilio Therapeutics, Zenith Epigenetics, Zenyaku Kogyo